Analytical treatment interruption (ATI) is a crucial component of HIV cure research, but discussions have largely focused on adult populations. A recent expert opinion from the EPIICAL consortium, published in The Lancet HIV,…
We are pleased to announce the successful completion of recruitment for the HVRRICANE study. The study, a collaboration between Penta, Bambino Gesù Paediatric Hospital in Rome (OPBG), the Henry M.…
Padova, Italy – 24 May 2024 Alarmingly high mortality rates persist for African infants with HIV despite early treatment, the Early Anti-Retroviral Treatment in Children (EARTH) study finds. The study…
The EPIICAL Consortium applauds the significant progress in the fight against HIV/AIDS in children, presented by Dr. Deborah Persaud at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). Research…
The CARMA Global study has successfully met its recruitment target and recruited 99 children and adolescents living with HIV from across the globe. The study includes children and adolescents who…
In the quest to enhance our understanding of paediatric HIV and improve treatment outcomes, the EPIICAL project has worked tirelessly for the past eight years to gather and generate knowledge on HIV…
The EPIICAL General Assembly was held online and in person in Venice on 2-4 November 2022. It brought together 80 participants from 29 organisations from the EPIICAL consortium. Attendees came…
In July and August 2022, as part of the preparations for the initiation of enrolments into CARMA Global, investigators and site staff were oriented on study procedures and the correct…
Congratulations to study teams on the acceptance of their abstracts to AIDS 2022
In 2016 the Early-treated Perinatally HIV-infected individuals: Improving Children’s Actual Life (EPIICAL) consortium began gathering scientists and clinicians specialising in paediatric HIV